Speaker Details

Kenneth B. Gordon, MD, FAAD

Kenneth B. Gordon, MD, FAAD

SESSIONS

S018 Psoriasis
Mar 8, 2024 • 1:00 PM - 4:00 PM • Room 20B
S026 Late-breaking Research: Session 1
Mar 9, 2024 • 9:00 AM - 12:00 PM • Room 20B
F066 So Many Biologics, So Little Time: How to Pick Your Poison in an Era of Biologic Overload
Mar 9, 2024 • 3:30 PM - 5:30 PM • Room 20A
S050 Late-Breaking Research: Session 2
Mar 10, 2024 • 1:00 PM - 4:00 PM • Room 20B
S058 Psoriasis: Modern Therapeutic Approaches
Mar 11, 2024 • 9:00 AM - 12:00 PM • Room 6A
F118 Psoriasis and Atopic Dermatitis: Advances in Comorbidities and Therapy
Mar 11, 2024 • 3:30 PM - 5:30 PM • Room 6A

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);